North America Blood Screening Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
North America blood screening market is expected to reach healthy CAGR of 9.6% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
- In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.
- In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.
- In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today’s world. The Blood screening method is found to be more useful for detecting cancer.
- In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.
- Enzo Biochem Inc.
- Meridian Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- BD
- bioMérieux SA
- Beckman Coulter, Inc.
- Abbott
- F. Hoffmann-La Roche Ltd
- Cepheid
- Grifols
- Seimens AG
- Ortho Clinical Diagnostics
- Immucor, Inc.
- Hologic Inc.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 NORTH AMERICA BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 NORTH AMERICA BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
LIST OF TABLES
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 NORTH AMERICA SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 NORTH AMERICA RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 NORTH AMERICA WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 NORTH AMERICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 NORTH AMERICA ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 NORTH AMERICA DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 NORTH AMERICA COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 NORTH AMERICA CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 NORTH AMERICA INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 NORTH AMERICA RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 NORTH AMERICA HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 NORTH AMERICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 NORTH AMERICA DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 NORTH AMERICA BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 NORTH AMERICA HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 NORTH AMERICA CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
Table 37 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET,BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 48 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 U.S. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 U.S. REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 U.S. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 U.S. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 U.S. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 U.S. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 60 U.S. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 CANADA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 62 CANADA REAGENTS & KITS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 63 CANADA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 64 CANADA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 65 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 66 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 67 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 68 CANADA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 69 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 70 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 71 CANADA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 72 CANADA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 73 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 74 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 75 MEXICO ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 76 MEXICO NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 77 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 78 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 79 MEXICO BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 80 MEXICO NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 81 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 82 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 83 MEXICO BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 84 MEXICO BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 NORTH AMERICA SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 NORTH AMERICA RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 NORTH AMERICA WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 NORTH AMERICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 NORTH AMERICA ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 NORTH AMERICA DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 NORTH AMERICA COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 NORTH AMERICA CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 NORTH AMERICA INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 NORTH AMERICA RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 NORTH AMERICA HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 NORTH AMERICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 NORTH AMERICA DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 NORTH AMERICA BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 NORTH AMERICA HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 NORTH AMERICA CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
Table 37 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET,BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 48 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 U.S. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 U.S. REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 U.S. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 U.S. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 U.S. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 U.S. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 60 U.S. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 CANADA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 62 CANADA REAGENTS & KITS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 63 CANADA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 64 CANADA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 65 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 66 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 67 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 68 CANADA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 69 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 70 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 71 CANADA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 72 CANADA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 73 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 74 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 75 MEXICO ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 76 MEXICO NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 77 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 78 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 79 MEXICO BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 80 MEXICO NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 81 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 82 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 83 MEXICO BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 84 MEXICO BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
LIST OF FIGURES
Figure 1 NORTH AMERICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 NORTH AMERICA BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 NORTH AMERICA BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 NORTH AMERICA BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 NORTH AMERICA BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 NORTH AMERICA BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 NORTH AMERICA BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 NORTH AMERICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 NORTH AMERICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 NORTH AMERICA BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA BLOOD SCREENING MARKET
Figure 12 NORTH AMERICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 16 NORTH AMERICA BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 17 NORTH AMERICA BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 18 NORTH AMERICA BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 19 NORTH AMERICA BLOOD SCREENING MARKET: BY END USER, 2017
Figure 20 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 21 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 22 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 23 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 24 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 25 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 1 NORTH AMERICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 NORTH AMERICA BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 NORTH AMERICA BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 NORTH AMERICA BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 NORTH AMERICA BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 NORTH AMERICA BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 NORTH AMERICA BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 NORTH AMERICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 NORTH AMERICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 NORTH AMERICA BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA BLOOD SCREENING MARKET
Figure 12 NORTH AMERICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 16 NORTH AMERICA BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 17 NORTH AMERICA BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 18 NORTH AMERICA BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 19 NORTH AMERICA BLOOD SCREENING MARKET: BY END USER, 2017
Figure 20 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 21 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 22 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 23 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 24 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 25 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
